COVID-19 Pneumonia
📧 Sign up to get email alerts when something new happens for COVID-19 Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease [Phase 1, Phase 2]
A safety-focused clinical trial update on nebulized BromAc® therapy for COVID-19-related respiratory conditions across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia [Phase 3]
Phase 3 trial evaluating remdesivir plus tocilizumab versus remdesivir plus placebo in hospitalized patients with severe COVID-19 pneumonia;…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients [Phase 2]
Phase 2 trial investigating the efficacy and safety of NuSepin® in COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Asunercept in Patients With Severe COVID-19 [Phase 2]
Phase 2 trial update for asunercept in patients with COVID-19–related pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19 [Phase 3]
A Phase 3 clinical trial evaluating nebulized fentanyl for respiratory symptoms in COVID-19 pneumonia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating MSTT1041A (Astegolimab) or UTTR1147A in patients with severe COVID-19 pneumonia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-23Clinical Trial Update: The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores [NA]
A completed clinical trial dataset for an oral COVID-19 vaccine using Bacillus subtilis spores has posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia [Phase 2]
Phase 2 trial update evaluating hzVSF-v13 for efficacy and safety in patients with COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating DV890 for efficacy and safety in patients with COVID-19 pneumonia has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes [Phase 4]
Phase 4 trial evaluating immunogenicity, safety and antibody persistence of a Wuhan-produced COVID-19 booster in patients with hypertension …
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes [Phase 4]
Phase 4 trial update evaluating immunogenicity, safety, and antibody persistence of a Beijing-produced COVID-19 booster vaccine in patients …
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Effect of Montelukast Therapy on Clinical Course, Pulmonary Function, and Mortality in Patients With COVID-19 [Phase 4]
Phase 4 clinical trial evaluating montelukast therapy effects on clinical course, pulmonary function, and mortality in COVID-19 pneumonia pa…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT [Phase 3]
Phase 3 randomized trial evaluating atorvastatin for reducing 28-day mortality in COVID-19; current status unknown.
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of a COVID-19 vaccine produced in Wuhan in patients with hypertension and/or diabetes (CO…
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of combined immunization with COVAX (produced in Wuhan) and PPV23 / IIV4.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia [Phase 4]
Pilot Phase 4 study assessing cefditoren pivoxil in adults with mild to moderate COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia [Phase 3]
Phase 3 trial update evaluating tocilizumab for COVID-19 pneumonia in hospitalized patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Safety and Effectiveness of an Immunobiological Drug in CoViD-19 [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update reports on the safety and effectiveness of an immunobiological drug for COVID-19 pneumonia and respi…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia [Phase 2]
Phase 2 trial update evaluating oral immunotherapy with GcMAF in hospitalized COVID-19 pneumonia patients reports efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating intravenous tocilizumab for moderate to severe COVID-19 pneumonia has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab [Phase 3]
A Phase 3 randomized trial investigating the effectiveness of tocilizumab for COVID-19 pneumonia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19 [Phase 3]
Phase 3 trial investigating whether cyproheptadine affects ventilatory support-free days in critically ill COVID-19 pneumonia patients; curr…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 [Phase 2]
Clinical trial evaluating three treatments for COVID-19 pneumonia (Phase 2) with unknown current status.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 [Phase 3]
Phase 3 clinical trial evaluating CKD-314 for COVID-19 pneumonia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: MANS-NRIZ Trial for COVID-19 Treatment : Extension Study [Phase 2, Phase 3]
Clinical trial update for the MANS-NRIZ extension study in COVID-19 pneumonia, spanning Phase 2 and Phase 3.